ATMPs Consulting Market Size, Share & Trends Analysis Report By Phase (Early-Stage Development, Clinical Development, Commercialization), By Type (Gene therapy medicinal products, Somatic cell medicinal products, Tissue-engineered medicinal products), By Region, And By Segment Forecasts, 2025-2034
ATMPs Consulting Market Size is predicted to witness a 8.6% CAGR during the forecast period for 2025-2034. Advanced therapy medical products (ATMPs) are human medicines based on genes, tissues, or cells. They provide new and novel therapeutic options for ailments and injuries. ATMPs primarily target diseases with significant unmet medical needs. The introduction of ATMPs has altered the pharmaceutical industry as well as the illness treatment la...
Report ID: 2152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Immunoturbidimetry Reagents Market Size, Share & Trends Analysis Report By Type (Common Immune Turbidimetric Reagent, Latex Enhanced Immune Turbidimetric Reagent), By Application (Glycated hemoglobin, Retinol Binding Protein, C-Reactive Protein, Anti-streptococcal hemolysin
Immunoturbidimetry Reagents Market Size is predicted to represent a 7.2% CAGR during the forecast period for 2025-2034. Immunoturbidimetry (IT) is a valuable diagnostic tool in clinical chemistry. It's utilized to find blood proteins that aren't detectable using typical clinical chemistry methods or the antigen-antibody reaction. Immunoturbidimetry is based on antigen-antibody interactions that are specific and sensitive. Each antibody recogni...
Report ID: 2200 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Size, Share & Trends Analysis Report, By Application (Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Pancreatic Cancer, and Others), By Region, Forecasts, 2025-2034
Global TROP2 (Trophoblast Cell-surface Antigen 2) Targeted Cancer Therapy Market Size is predicted to expand at a 9.8% CAGR during the forecast period for 2025-2034. The surge in cancer prevalence and the trend toward personalized treatment serve as the primary drivers of market expansion. The quest for novel therapeutic targets is imperative to offer improved treatment options for the escalating number of cancer cases. TROP2 has eme...
Report ID: 2493 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Live biotherapeutic/Microbiome Based Therapeutics Market Size, Share & Trends Analysis Report By Product (VOWST (SER-109), REBYOTA, Visbiome, Other Pipeline Products), By Route of Administration (Oral Therapeutics, Rectal Therapeutics), By Target Disease Indication (Recurrent C. Difficile Infection, Dietary Management of Microbial Imbalance, Other Indications), By Distribution Channel, By End User, By Region, And Segment Forecasts, 2025-2034
Live biotherapeutic/Microbiome Based Therapeutics Market Size is valued at USD 73.25 Bn in 2024 and is predicted to reach USD 142.81 Bn by the year 2034 at a 7.04% CAGR during the forecast period for 2025-2034. A live microbe is utilized in a Live Biotherapeutic product to treat, prevent, or cure a disease. Microorganisms that may be beneficial to health have been discovered as the human ...
Report ID: 1300 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Lipid-Nanoparticle Based Genomic Medicines Market Size, Share & Trends Analysis Report By Products (D2C Gut Health Test, Probiotic Supplements, Personalized Nutrition, Microbiome Modulators, Ingredients, Medical Foods, Therapeutics), By End-User (Adult, Maternal, Infant), By Region, And By Segment Forecasts, 2025-2034
Lipid-Nanoparticle Based Genomic Medicines Market Size is valued at USD 2.58 Bn in 2024 and is predicted to reach USD 38.04 Bn by the year 2034 at a 31.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The shift towards customized medicine is driving the lipid-nanoparticle-based genomic medicines market. The rise in mRNA-based therapeutics, enabled by lipid nanoparticles, is a signif...
Report ID: 2380 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Somatropin Market Size, Share & Trends Analysis Report By Applications (Chronic Renal Insufficiency, Growth Hormone Deficiency, Turners Syndrome, Prader-Willi Syndrome, Idiopathic Short Stature, and Noonan Syndrome), By Distribution Channel, Region And Segment Forecasts, 2025-2034
Somatropin Market is expected to grow at a 7.5% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: One factor driving the growing demand for somatropin is the increasing frequency of growth hormone deficiency diagnoses in both adults and children, while another is the improvement in medical diagnostic technology, which permits earlier and more precise identification of growth hormone deficie...
Report ID: 1111 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Neoantigen Cancer Vaccine Market Size, Share & Trends Analysis Report By Product (Personalized and Off-The-Shelf Neoantigen Vaccines), By Neovaccine Type, By Therapeutic Area, By Therapy Type, Region And Segment Forecasts, 2025-2034
Global Neoantigen Cancer Vaccine Market is expected to grow at a 20.0% CAGR during the forecast period for 2025-2034. Neoantigen Cancer Vaccines are vaccines that assist in boosting the immune system by using a single or several antigens. The antigens generally consist of several peptides or proteins. Neoantigens are a mutated or a new type of antigen present only in cancer cells and not in rest normal cells. Neoantigen Cancer Vaccines stimulate...
Report ID: 1117 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size, Share & Trends Analysis Report By Type of Services (Development Services, Manufacturing Services, and Others (Regulatory expertise and support, Quality Control and Assurance)), By Scale of operations, By Application, By Region, And By Segment Forecasts, 2025-2034.
The Live Biotherapeutic Products And Microbiome Contract Manufacturing Market Size is valued at 230.8 Million in 2024 and is predicted to reach 1,456.9 Million by the year 2034 at a 18.1% CAGR during the forecast period for 2025-2034 Key Industry Insights & Findings from the Report: Increasing R&D activities aimed at redefining the development of next-generation live biotherapeutic and microbiome contract manufac...
Report ID: 1152 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Gene Therapy for Blood Disorders Market Size, Share & Trends Analysis Report By Indication (Sickle Cell Anemia, ?-thalassemia, Hemophilia B, Hemophilia A), By Mechanism of Action (Gene Therapy, Gene Editing), By Region, And Segment Forecasts, 2025-2034
Gene Therapy for Blood Disorders Market Size is estimated to grow at a 15.3% CAGR during the forecast period for 2025-2034. The Arena of Gene Therapy is determined to outline a path to the clinic and the market. In the gene therapy market, over 2000 human gene therapy clinical trials have been reported globally, and about 20 gene therapy products are approved to treat various disorders. Hence, the demand for gene therapy to treat blood disorde...
Report ID: 1156 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Neuropsychiatric Drugs Market Size, Share & Trends Analysis Report By Drug Type (Typical Antipsychotics and Atypical Antipsychotics), By Indication, By Route Of Administration, Region And Segment Forecasts, 2025-2034.
Neuropsychiatric Drugs Market is expected to grow at a 5.0% CAGR during the forecast period for 2025-2034. Neuropsychiatric disorders are psychological disorder occur owing to a functional disturbance in the cerebral system. According to the National Institutes of Health, Neuropsychiatric disorders are one of the top 10 leading causes of global disability-adjusted life years (DALYs). The neuropsychiatry is concerned with illnesses of behavior ...
Report ID: 1170 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Pharmaceuticals